LeonaBio (LONA) Other Accumulated Expenses (2019 - 2026)

LeonaBio (LONA) has 8 years of Other Accumulated Expenses data on file, last reported at $1.3 million in Q1 2026.

• On a quarterly basis, Other Accumulated Expenses fell 46.75% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 46.75% decrease from a year earlier, with the FY2025 full-year figure at $2.0 million, down 41.24% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $1.3 million, down from $2.0 million in the prior quarter.
• Over the last five years, Other Accumulated Expenses for LONA reached as high as $11.9 million in Q4 2023 and fell as low as $738000.0 in Q3 2025.
• Historically, Other Accumulated Expenses has averaged $5.7 million across 5 years, with a median of $5.1 million in 2022.
• Across the five-year window, Other Accumulated Expenses soared 210.07% in 2023 and tumbled 90.86% in 2025, its largest moves.
• Year by year, Other Accumulated Expenses stood at $3.8 million in 2022, then surged by 210.07% to $11.9 million in 2023, then slumped by 71.27% to $3.4 million in 2024, then tumbled by 41.24% to $2.0 million in 2025, then tumbled by 33.7% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $1.3 million in Q1 2026, $2.0 million in Q4 2025, and $738000.0 in Q3 2025.